Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes

被引:29
|
作者
Fukuda, Masakazu [1 ]
Yamamoto, Takeshi [1 ]
Nishimura, Shigehiko [1 ]
Kato, Takayoshi [1 ]
Murakami, Wakako [1 ]
Hino, Akihiro [1 ]
Ono, Makoto [1 ]
Tateishi, Hiroki [1 ]
Oda, Testuro [1 ]
Okuda, Shinichi [1 ]
Kobayashi, Shigeki [1 ]
Koseki, Noritaka [2 ]
Kyushiki, Hiroyuki [2 ]
Yano, Masafumi [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 7558505, Japan
[2] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima 7710192, Japan
关键词
Calmodulin; Ryanodine receptor; Sarcoplasmic reticulum; Calcium; CPVT; CARDIAC RYANODINE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; CA2+ RELEASE CHANNEL; IN MOUSE MODEL; FAILING HEARTS; INTERDOMAIN INTERACTIONS; MALIGNANT HYPERTHERMIA; THERAPEUTIC AGENT; KEY ROLE; DYSFUNCTION;
D O I
10.1016/j.bbrc.2014.03.152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: Calmodulin (CaM) plays a key role in modulating channel gating in ryanodine receptor (RyR2). Here, we investigated (a) the pathogenic role of CaM in the channel disorder in CPVT and (b) the possibility of correcting the CPVT-linked channel disorder, using knock-in (RI) mouse model with CPVT-associated RyR2 mutation (R24745). Methods and results: Transmembrane potentials were recorded in whole cell current mode before and after pacing (1-5 Hz) in isolated ventricular myocytes. CaM binding was assessed by incorporation of exogenous CaM fluorescently labeled with HiLyte Fluor (R) in saponin-permeabilized myocytes. In the presence of cAMP (1 mu M) the apparent affinity of CaM binding to the RyR decreased in IC cells (Kd: 140-400 nM), but not in WT cells (Kd: 110-120 nM). Gly-Ser-His-CaM (GSH-CaM that has much higher RyR-binding than CaM) restored normal binding to the RyR of cAMP-treated KI cells (140 nM). Neither delayed afterdepolarization (DAD) nor triggered activity (TA) were observed in WT cells even at 5 Hz pacing, whereas both DAD and TA were observed in 20% and 12% of IU cells, respectively. In response to 10 nM isoproterenol, only DAD (but not TA) was observed in 11% of WT cells, whereas in KI cells the incidence of DAD and TA further increased to 60% and 38% of cells, respectively. Addition of GSH-CaM (100 nM) to RI cells decreased both DADs and TA (DAD: 38% of cells; TA: 10% of cells), whereas CaM (100 nM) had no appreciable effect. Addition of GSH-CaM to saponin-permeabilized IC cells decreased Ca2+ spark frequency (+33% of WT cells), which otherwise markedly increased without GSH-CaM (+100% of WT cells), whereas CaM revealed much less effect on the Ca2+ spark frequency (+76% of WT cells). Then, by incorporating CaM or GSH-CaM to intact cells (with protein delivery kit), we assessed the in situ effect of GSH-CaM (cytosolic [CaM] = 240 nM, cytosolic [GSH-CaM] = 230 nM) on the frequency of spontaneous Ca2+ transient (sCaT, % of total cells). Addition of 10 nM isoproterenol to ICI cells increased sCaT after transient 5 Hz pacing (37%), whereas it was much more attenuated by GSH-CaM (9%) than by CaM (26%) (P < 0.01 vs CaM). Conclusions: Several disorders in the RyR channel function characteristic of the CPVT-mutant cells (increased spontaneous Ca2+ leak, delayed afterdepolarization, triggered activity, Ca2+ spark frequency, spontaneous Ca2+ transients) can be corrected to a normal function by increasing the affinity of CaM binding to the RyR. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 23 条
  • [1] Enchanced Binding of Calmodulin to RyR2 Inhibits Aberrant Ca2+Release and Arrhythmogenesis in CPVT-Associated Mutuation
    Fukuda, Masakazu
    Yamamoto, Takeshi
    Kato, Takayoshi
    Hino, Akihiro
    Suetomi, Takeshi
    Tateishi, Hiroki
    Doi, Masahiro
    Okuda, Shinichi
    Kobayashi, Shigeki
    Matsuzaki, Masunori
    Yano, Masafumi
    CIRCULATION, 2012, 126 (21)
  • [2] Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction
    Xu, Xiaojuan
    Yano, Masafumi
    Uchinoumi, Hitoshi
    Hino, Akihiro
    Suetomi, Takeshi
    Ono, Makoto
    Tateishi, Hiroki
    Oda, Tetsuro
    Okuda, Shinichi
    Doi, Masahiro
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Ikemoto, Noriaki
    Matsuzaki, Masunori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) : 660 - 666
  • [3] Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure
    Kato, Takayoshi
    Yamamoto, Takeshi
    Nakamura, Yoshihide
    Nanno, Takuma
    Fukui, Go
    Sufu, Yoko
    Hamada, Yoriomi
    Maeda, Takako
    Nishimura, Shigehiko
    Ishiguchi, Hironori
    Murakami, Wakako
    Fukuda, Masakazu
    Xu, Xiaojuan
    Hino, Akihiro
    Ono, Makoto
    Oda, Tetsuro
    Okuda, Shinichi
    Kobayashi, Shigeki
    Koseki, Noritaka
    Kyushiki, Hiroyuki
    Yano, Masafumi
    HEART RHYTHM, 2017, 14 (01) : 120 - 127
  • [4] Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks
    Gomez-Hurtado, Nieves
    Boczek, Nicole J.
    Kryshtal, Dmytro O.
    Johnson, Christopher N.
    Sun, Jennifer
    Nitu, Florentin R.
    Cornea, Razvan L.
    Chazin, Walter J.
    Calvert, Melissa L.
    Tester, David J.
    Ackerman, Michael J.
    Knollmann, Bjorn C.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (08)
  • [5] Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2
    Lavorato, Manuela
    Huang, Tai-Qin
    Iyer, Venkat Ramesh
    Perni, Stefano
    Meissner, Gerhard
    Franzini-Armstrong, Clara
    JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2015, 36 (02) : 205 - 214
  • [6] Dantrolene Enhances Binding of Calmodulin to RyR2 in CPVT Which Mutation Located at Central Domain but Does Not Enhance That in CPVT With Mutation at CaM-like Domain
    Nishimura, Shigehiko
    Yamamoto, Takeshi
    Fukui, Go
    Maeda, Takako
    Hino, Akihiro
    Suetomi, Takeshi
    Ono, Makoto
    Mochizuki, Mamoru
    Oda, Tetsuro
    Okuda, Shinichi
    Kobayashi, Shigeki
    Yano, Masafumi
    CIRCULATION, 2015, 132
  • [7] RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT
    Kryshtal, Dmytro O.
    Blackwell, Daniel J.
    Egly, Christian L.
    Smith, Abigail N.
    Batiste, Suzanne M.
    Johnston, Jeffrey N.
    Laver, Derek R.
    Knollmann, Bjorn C.
    CIRCULATION RESEARCH, 2021, 128 (03) : 321 - 331
  • [8] The CPVT-associated RyR2 mutation G230C enhances store overload-induced Ca2+ release and destabilizes the N-terminal domains
    Liu, Yingjie
    Kimlicka, Lynn
    Hiess, Florian
    Tian, Xixi
    Wang, Ruiwu
    Zhang, Lin
    Jones, Peter P.
    Van Petegem, Filip
    Chen, S. R. Wayne
    BIOCHEMICAL JOURNAL, 2013, 454 : 123 - 131
  • [9] Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2
    Manuela Lavorato
    Tai-Qin Huang
    Venkat Ramesh Iyer
    Stefano Perni
    Gerhard Meissner
    Clara Franzini-Armstrong
    Journal of Muscle Research and Cell Motility, 2015, 36 : 205 - 214
  • [10] Correction of Defective Calmodulin Binding to Cardiac Ryanodine Receptor Inhibits Aberrant Ca2+ Release in CPVT-associated Mutation
    Fukuda, Masakazu
    Yano, Masafumi
    Hino, Akihiro
    Suetomi, Takeshi
    Xu, Xiaojuan
    Ono, Makoto
    Uchinoumi, Hitoshi
    Doi, Masahiro
    Okuda, Shinichi
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Matsuzaki, Masunori
    CIRCULATION, 2010, 122 (21)